| Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised … DH Brand, AC Tree, P Ostler, H van der Voet, A Loblaw, W Chu, D Ford, ... The Lancet Oncology 20 (11), 1531-1543, 2019 | 446 | 2019 |
| Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement RC Chen, RB Rumble, DA Loblaw, A Finelli, B Ehdaie, MR Cooperberg, ... Journal of Clinical Oncology 34 (18), 2182-2190, 2016 | 411 | 2016 |
| External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative … TJ Whelan, JA Julian, TS Berrang, D Kim, I Germain, AM Nichol, M Akra, ... The Lancet 394 (10215), 2165-2172, 2019 | 350 | 2019 |
| Hypofractionated radiation therapy for localized prostate cancer: executive summary of an ASTRO, ASCO, and AUA evidence-based guideline SC Morgan, K Hoffman, DA Loblaw, MK Buyyounouski, C Patton, ... Practical radiation oncology 8 (6), 354-360, 2018 | 200 | 2018 |
| Hypofractionated radiation therapy for localized prostate cancer: An ASTRO, ASCO, and AUA evidence-based guideline SC Morgan, K Hoffman, DA Loblaw, MK Buyyounouski, C Patton, ... Journal of Clinical Oncology 36 (34), 3411-3430, 2018 | 181 | 2018 |
| Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non … AC Tree, P Ostler, H van der Voet, W Chu, A Loblaw, D Ford, S Tolan, ... The Lancet Oncology 23 (10), 1308-1320, 2022 | 163 | 2022 |
| Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: a systematic review and meta-analysis SC Morgan, TS Waldron, L Eapen, LA Mayhew, E Winquist, H Lukka, ... Radiotherapy and Oncology 88 (1), 1-9, 2008 | 102 | 2008 |
| Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: dosimetric evaluation JM Caudrelier, SC Morgan, L Montgomery, M Lacelle, B Nyiri, ... Radiotherapy and Oncology 90 (1), 99-105, 2009 | 99 | 2009 |
| Initial management of noncastrate advanced, recurrent, or metastatic prostate cancer: ASCO guideline update KS Virgo, RB Rumble, R de Wit, DS Mendelson, TJ Smith, ME Taplin, ... Journal of Clinical Oncology 39 (11), 1274-1305, 2021 | 91 | 2021 |
| Hypofractionated radiation therapy for localized prostate cancer: executive summary of an ASTRO, ASCO and AUA evidence-based guideline SC Morgan, K Hoffman, DA Loblaw, MK Buyyounouski, C Patton, ... The Journal of urology 201 (3), 528-534, 2019 | 79 | 2019 |
| Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta‐analysis N Gandhi, S Krishna, CM Booth, RH Breau, TA Flood, SC Morgan, ... BJU international 122 (5), 744-753, 2018 | 78 | 2018 |
| Stereotactic radiotherapy for oligoprogression in metastatic renal cell cancer patients receiving tyrosine kinase inhibitor therapy: a phase 2 prospective multicenter study P Cheung, S Patel, SA North, A Sahgal, W Chu, H Soliman, B Ahmad, ... European Urology 80 (6), 693-700, 2021 | 75 | 2021 |
| Prostate radiotherapy with adjuvant androgen deprivation therapy (ADT) improves metastasis-free survival compared to neoadjuvant ADT: an individual patient meta-analysis DE Spratt, S Malone, S Roy, S Grimes, L Eapen, SC Morgan, J Malone, ... Journal of Clinical Oncology 39 (2), 136-144, 2021 | 68 | 2021 |
| Sequencing of androgen-deprivation therapy with external-beam radiotherapy in localized prostate cancer: A phase III randomized controlled trial S Malone, S Roy, L Eapen, C E, R MacRae, G Perry, J Bowen, R Samant, ... Journal of Clinical Oncology 38 (6), 593, 2020 | 61 | 2020 |
| 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International … S Siva, M Ali, RJM Correa, A Muacevic, L Ponsky, RJ Ellis, SS Lo, ... The Lancet Oncology 23 (12), 1508-1516, 2022 | 56 | 2022 |
| Local treatment of metastatic cancer—killing the seed or disturbing the soil? SC Morgan, CC Parker Nature reviews Clinical oncology 8 (8), 504-506, 2011 | 53 | 2011 |
| CT assessment of conjugate eye deviation in acute stroke JE Simon, SC Morgan, JHW Pexman, MD Hill, AM Buchan Neurology 60 (1), 135-7, 2003 | 48 | 2003 |
| Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: A Cancer Care Ontario clinical practice guideline J Salerno, A Finelli, C Morash, SC Morgan, N Power, N Schieda, ... Canadian Urological Association Journal 10 (9-10), E332, 2016 | 42 | 2016 |
| Bone health and bone-targeted therapies for prostate cancer: a programme in evidence-based care—cancer care ontario clinical practice guideline SMH Alibhai, K Zukotynski, C Walker-Dilks, U Emmenegger, A Finelli, ... Clinical Oncology 29 (6), 348-355, 2017 | 41 | 2017 |
| Bone health and bone-targeted therapies for nonmetastatic prostate cancer: a systematic review and meta-analysis SMH Alibhai, K Zukotynski, C Walker-Dilks, U Emmenegger, A Finelli, ... Annals of internal medicine 167 (5), 341-350, 2017 | 40 | 2017 |
